🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07559552
Starting soon Not applicable

ACT-Based Group Therapy and Mobile Application Intervention for Emotional Eating

NCT07559552 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-15
Last updated
2026-04-30

Condition(s) studied

Emotional EatingEmotion RegulationOverweightPsychological Flexibility

Investigational drug(s) / intervention(s)

ACT-Based Group TherapyACT-Based Mobile Application

ACT-Based Group Therapy: The Acceptance and Commitment Therapy (ACT)-based group therapy program is structured as one session per week for six weeks. Sessions will last 60-90 minutes. The sessions will focus on the core ACT processes: acceptance, cognitive dissociation, being present, contextual self, value identification, and value-oriented action. Psychoeducation, experiential exercises, mindfulness practices, and group sharing will be used during the sessions. Homework and practice tasks will be assigned between sessions to support participants in applying the skills they learn to their daily lives.

ACT-Based Mobile Application: The ACT-based mobile application was developed to support the therapy process. The application offers psychoeducational content, ACT-based exercises, reminders, motivational messages, and tools to support the application of skills in daily life. It also allows users to monitor their mood and eating behaviors.

Study summary

This study aims to evaluate the effects of an Acceptance and Commitment Therapy (ACT)-based group therapy program, combined with an ACT-based mobile app, on emotional eating, emotion regulation, and psychological flexibility in overweight individuals. Emotional eating is a condition in which individuals frequently use eating behavior as a coping mechanism for negative emotions.

Participants will be randomly assigned to intervention groups receiving ACT-based group therapy, ACT-based group therapy combined with an ACT-based mobile app, or a control group. The intervention will last six weeks and will include structured group sessions as well as mobile-based exercises, reminders, and coping strategies.

Outcome measures will include emotional eating, emotion regulation, and psychological flexibility. Assessments will be conducted at baseline, post-intervention, and during the follow-up phase. The findings of this study are expected to contribute to the development of accessible and effective interventions for emotional eating.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Agreeing to participate in the study, * Being between 18-65 years of age, * Having a body mass index ≤ 25 (BMI ≤ 29.9), * Being able to read and write, * Having an iOS or Android smartphone, * Having internet access, * Having a home environment suitable for online sessions (having a computer/smartphone, internet access at home, the patient being able to be alone in the room during the session, etc.), Exclusion Criteria: * Having communication problems that would prevent the interview, * Having a diagnosis of a mental disorder, including an eating disorder, that would prevent participation in the study, or having concomitant serious medical conditions that could potentially jeopardize study participation. * Having undergone bariatric surgery. • Being on the waiting list for bariatric surgery. * Being pregnant, breastfeeding, or planning to become pregnant within the next 6 months. * Receiving therapy/counseling for emotional eating and emotion regulation problems, * Using a mobile application for emotional eating and emotion regulation problems,

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zonguldak Atatürk State Hospital Zonguldak Merkez

More Saglik Bilimleri Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07559552 on ClinicalTrials.gov ↗ ← All trials in Turkey